Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 May;3(3):e210038.
doi: 10.1148/rycan.2021210038.

COVID-19 Vaccination-Related Lymphadenopathy: What To Be Aware Of

Wendy Tu  1 , David S Gierada  2 , Bonnie N Joe  3
Affiliations
Editorial

COVID-19 Vaccination-Related Lymphadenopathy: What To Be Aware Of

Wendy Tu et al. Radiol Imaging Cancer. 2021 May.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Disclosures: Dr. Joe is a deputy editor of Radiology: Imaging Cancer, Dr. Gierada is an associate editor of Radiology: Imaging Cancer, Dr. Tu is a trainee editorial board member of Radiology: Imaging Cancer.

Figures

69-year-old female with a history of lung adenocarcinoma and recent left arm COVID-19 vaccination three days prior (first dose). (A) Axial images from chest CT show left axillary and subpectoral lymphadenopathy (arrows) (B) Comparison chest CT images from one-year prior show normal left axillary lymph nodes.
Figure 1A:
69-year-old female with a history of lung adenocarcinoma and recent left arm COVID-19 vaccination three days prior (first dose). (A) Axial images from chest CT show left axillary and subpectoral lymphadenopathy (arrows) (B) Comparison chest CT images from one-year prior show normal left axillary lymph nodes.
69-year-old female with a history of lung adenocarcinoma and recent left arm COVID-19 vaccination three days prior (first dose). (A) Axial images from chest CT show left axillary and subpectoral lymphadenopathy (arrows) (B) Comparison chest CT images from one-year prior show normal left axillary lymph nodes.
Figure 1B:
69-year-old female with a history of lung adenocarcinoma and recent left arm COVID-19 vaccination three days prior (first dose). (A) Axial images from chest CT show left axillary and subpectoral lymphadenopathy (arrows) (B) Comparison chest CT images from one-year prior show normal left axillary lymph nodes.
See this image and copyright information in PMC

Comment on

References

    1. Centers for Disease Control and Prevention, Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Moderna COVID-19 Vaccine.
    1. Centers for Disease Control and Prevention, Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine.
    1. Newfield, L., J.E. Naschitz, and D. Yeshurun, [BCG-induced axillary lymph-adenitis in the adult]. Harefuah, 1990. 119(7-8): p. 199–200. - PubMed
    1. Studdiford, J., et al. , Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination. Pharmacotherapy, 2008. 28(9): p. 1194–7. - PubMed
    1. Shirone, N., et al. , Axillary lymph node accumulation on FDG-PET/CT after influenza vaccination. Ann Nucl Med, 2012. 26(3): p. 248–52. - PubMed

LinkOut - more resources